As of Jan 20
| +0.98 / +0.90%|
The 26 analysts offering 12-month price forecasts for Bayer have a median target of 115.33, with a high estimate of 142.50 and a low estimate of 93.38. The median estimate represents a +5.51% increase from the last price of 109.31.
The current consensus among 26 polled investment analysts is to Buy stock in Bayer. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.